Trial NCT03739606

View at ClinicalTrials.gov 
Org. Study IDs: 18368
Secondary IDs: 18368 NCI-2018-02320

Last trial update was posted on 2020-12-17

MeSH Interventions

Antibodies Antibodies, Bispecific Antibodies, Monoclonal Immunoglobulins

MeSH Conditions

Hematologic Neoplasms Hodgkin Disease Leukemia Leukemia, Biphenotypic, Acute Leukemia, Hairy Cell Leukemia, Lymphoid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Lymphoma Mastocytosis Mastocytosis, Systemic Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Recurrence

Other Conditions

Acute Biphenotypic Leukemia Acute Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hairy Cell Leukemia Interleukin-3 Receptor Subunit Alpha Positive Recurrent Acute Lymphoblastic Leukemia Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Hematologic Malignancy Recurrent Hodgkin Lymphoma Refractory Acute Lymphoblastic Leukemia Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory Hematologic Malignancy Refractory Hodgkin Lymphoma Systemic Mastocytosis

Stopping Reasons

RSS recommendation

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID